Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
Stephen Padilla, 4 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).

Parents of preemies in the NICU suffer from poor HRQoL

02 Oct 2019
The Kangaroo Mother Care (KMC) idea, which originated amid grinding poverty, may be a cheaper and better option than incubators in saving premature babies.

Neonatal intensive care unit (NICU) hospitalization has a strong negative impact on health-related quality of life (HRQoL) of parents of extremely preterm infants, a recent study has found. The rebound in HRQoL after discharge is similarly great.

The present study included 194 parents of infants admitted to the NICU for 14 days. The Paediatric Quality of Life Inventory Family Impact Module was used to measure HRQoL before and 3 months after discharge. Infants transferred to the cardiac intensive care and nonbiological parents were excluded.

During NICU admission, parents of extremely preterm infants had significantly lower HRQoL than other parents. Multivariable linear regression analysis verified these findings and found that those whose babies were born at 23–28 weeks of gestation suffered from significantly worse HRQoL during NICU hospitalization (coefficient, –7.0; 95 percent CI, –12.6 to –1.4; p=0.015) relative to those of infants born 29–36 weeks of gestation.

In contrast, those whose babies were born 37–43 weeks of gestation did not show significantly lowered HRQoL (p=0.721).

When surveyed again 3 months after discharge, 67 percent of parents of extremely preterm infants reported clinically meaningful HRQoL improvements. In comparison, only 31 percent of parents of term infants reported the same.

“Future work in NICUs serving families with different demographics than ours, or in communities with different follow-up structures, will be important to understand the potential applications of these findings,” said researchers.

“Earlier discharge planning integrated with ongoing family education may be essential to optimizing both parent HRQoL and infant safety,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
Stephen Padilla, 4 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).